Pulmonary Epithelial Lining Fluid Concentrations after Use of Systemic Amphotericin B Lipid Formulations

Por Weiler, Stefan, Falkensammer, Gerda, Hammerer-Lercher, Angelika, Anliker, Markus, Vogelsinger, Helene, Joannidis, Michael, Dunzendorfer, Stefan, Stein, Markus, Bellmann, Romuald
Publicado em 2009

A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient

Por Anliker, Markus, von Zabern, Inge, Höchsmann, Britta, Kyrieleis, Henriette, Dohna-Schwake, Christian, Flegel, Willy A., Schrezenmeier, Hubert, Weinstock, Christof
Publicado no Transfusion (2014)

Comparative analysis of novel complement-targeted inhibitors, miniFH, and the natural regulators Factor H and Factor H-like protein 1 reveal functional determinants of complement r...

Por Harder, Markus J., Anliker, Markus, Höchsmann, Britta, Simmet, Thomas, Huber-Lang, Markus, Schrezenmeier, Hubert, Ricklin, Daniel, Lambris, John D., Barlow, Paul N., Schmidt, Christoph Q.
Publicado no J Immunol (2015)

Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation

Por Harder, Markus J., Kuhn, Nadine, Schrezenmeier, Hubert, Höchsmann, Britta, von Zabern, Inge, Weinstock, Christof, Simmet, Thomas, Ricklin, Daniel, Lambris, John D., Skerra, Arne, Anliker, Markus, Schmidt, Christoph Q.
Publicado no Blood (2017)

Selectivity of C3-opsonin targeted complement inhibitors: a distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients

Por Schmidt, Christoph Q., Harder, Markus J., Nichols, Eva-Maria, Hebecker, Mario, Anliker, Markus, Höchsmann, Britta, Simmet, Thomas, Csincsi, Ádám I., Uzonyi, Barbara, Pappworth, Isabel Y., Ricklin, Daniel, Lambris, John D., Schrezenmeier, Hubert, Józsi, Mihály, Marchbank, Kevin J.
Publicado no Immunobiology (2016)